Source: https://patents.google.com/patent/US7960145
Timestamp: 2018-02-25 16:06:18
Document Index: 503857904

Matched Legal Cases: ['Application No. 02729092', 'Application No. 02729092', 'Application No. 2004311630', 'Application No. 2004311630', 'Application No. 200480041234', 'Application No. 200480041234']

US7960145B2 - Compositions and methods for generating antibodies - Google Patents
US7960145B2
US7960145B2 US12267847 US26784708A US7960145B2 US 7960145 B2 US7960145 B2 US 7960145B2 US 12267847 US12267847 US 12267847 US 26784708 A US26784708 A US 26784708A US 7960145 B2 US7960145 B2 US 7960145B2
US12267847
US20090148908A1 (en )
US12267847 2007-11-08 2008-11-10 Compositions and methods for generating antibodies Active 2028-12-20 US7960145B2 (en)
US98649407 true 2007-11-08 2007-11-08
US12407908 true 2008-04-11 2008-04-11
US12267847 US7960145B2 (en) 2007-11-08 2008-11-10 Compositions and methods for generating antibodies
US13106745 US8486663B2 (en) 2007-11-08 2011-05-12 Compositions and methods for generating antibodies
US13106745 Continuation US8486663B2 (en) 2007-11-08 2011-05-12 Compositions and methods for generating antibodies
US20090148908A1 true US20090148908A1 (en) 2009-06-11
US7960145B2 true US7960145B2 (en) 2011-06-14
ID=40626223
US12267847 Active 2028-12-20 US7960145B2 (en) 2007-11-08 2008-11-10 Compositions and methods for generating antibodies
US13106745 Active US8486663B2 (en) 2007-11-08 2011-05-12 Compositions and methods for generating antibodies
US (2) US7960145B2 (en)
CA (1) CA2706700A1 (en)
EP (1) EP2219458B1 (en)
WO (1) WO2009062151A1 (en)
US20110275123A1 (en) * 2007-11-08 2011-11-10 Paciotti Giulio F Compositions and methods for generating antibodies
GB201003088D0 (en) * 2010-02-24 2010-04-14 Univ Exeter Method for the preparation of a novel nanoparticle conjugate
CA2850694A1 (en) * 2011-11-23 2013-05-30 F. Hoffmann-La Roche Ag Cd40l expressing mammalian cells and their use
EP0179483B1 (en) 1984-10-26 1991-12-11 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Method for preparing monoclonal antibodies to hbsag
WO1999024077A2 (en) 1997-11-10 1999-05-20 Cytimmune Sciences, Inc. Compositions and methods for targeted delivery of biologically-active factors
WO2002087509A2 (en) 2001-04-30 2002-11-07 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US20030053983A1 (en) 1997-11-10 2003-03-20 Lawrence Tamarkin Colloidal metal compositions and methods
US20040054139A1 (en) 2000-06-22 2004-03-18 Mark Page Modification of hepatitis b core antigen
US20040204576A1 (en) 2002-07-02 2004-10-14 Donald Jackson Polynucleotides encoding a novel human phosphatase, BMY_HPP13
US20070014798A1 (en) 1998-05-11 2007-01-18 Ernst Peter Rieber Antibodies to dendritc cells and human dendritic cell populations and uses thereof
US3191413A (en) * 1962-08-28 1965-06-29 Baldwin Lima Hamilton Corp Extrusion apparatus with removable die insert
EP0156242B1 (en) 1984-03-13 1992-03-25 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Lyophilized hepatitis b vaccine
US20040213760A1 (en) 1994-03-18 2004-10-28 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US20070231408A1 (en) 2001-04-30 2007-10-04 Lawrence Tamarkin Colloidal metal compositions and methods
EP1401376B1 (en) 2001-04-30 2016-11-30 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
WO2005065121A3 (en) 2003-12-02 2005-12-29 Cytimmune Sciences Inc Methods and compositions for the production of monoclonal antibodies
WO2005072893A1 (en) 2004-01-28 2005-08-11 Cytimmune Sciences, Inc. Functionalized colloidal metal compositions and methods
Author: Bae et al., Title: Thermo-Sensitive Pluronic Micelles Stabilized by Shell Crossing-Linking with Gold Nanoparticles, pp. 1-4, Date: Mar. 10, 2006.
Author: Balkwill et al., Title: The Cytokine Network, Publ: Immunology Today, vol./Iss: 10 (9), pp. 299-304, Date: Jan. 1, 1989.
Author: Borrebaeck et al., Title: Human Monoclonal Antibodies Produced by Primary in Vitro Immunization of Peripheral Blood Lymphocytes, Publ: Proceedings of the National Academy of Science USA, vol./Iss: 85, pp. 3995-3999, Date: Jun. 1, 1988.
Author: Brust et al., Title: Novel Gold-Dithiol Nano-Networks with Non-Metallic Electronic Properties, Publ: Advanced Materials, vol./Iss: 7 (9), pp. 795-797, Date: Jan. 1, 1995.
Author: Calabresi et al., Title: Chemotherapy of Neoplastic Diseases, Publ: Goodman & Gilman's The Pharmacological Basis of Therapeutics, vol./Iss: 9th Edition, pp. 1225-1232, Date: Jan. 1, 1996.
Author: Ciesiolka et al., Title: An 8- to 10-fold Enhancement in Sensitivity for Quanitation of Proteins by Modified Application of Colloidal Gold, Publ: Analytical Biochemistry, vol./Iss: 168 (2), pp. 280-283, Date: Feb. 1, 1988.
Author: Coulombe et al., Title: Cytochemical Demonstration of Increased Phospholipid Content in Cell Membranes in Chlorphentermine-Induced Phospholipidosis, Publ: Journal of Histochemistry and Cytochemistry, vol./Iss: 37 (2), pp. 139-147, Date: Jan. 1, 1989.
Author: De Brabander et al., Title: Probing Microtubule-Dependent Intracellular Motility with Nanometric Particle Video Ultramicroscopy (nanovid ultramicroscopy) (Abstract Only-Applicants do not have complete copy), Publ: Cytobios, vol./Iss: 43, pp. 273-283, Date: Jan. 1, 1985.
Author: De Brabander et al., Title: Probing Microtubule-Dependent Intracellular Motility with Nanometric Particle Video Ultramicroscopy (nanovid ultramicroscopy) (Abstract Only—Applicants do not have complete copy), Publ: Cytobios, vol./Iss: 43, pp. 273-283, Date: Jan. 1, 1985.
Author: Deng et al., Title: Self-Assembled Monolayers of Alkanethiolates Presenting Tri(propylene sulfoxide) Groups Resist the Adsorption of Protein, Publ: Journal of the American Chemical Society, vol./Iss: 118 (19), pp. 5136-5137, Date: May 15, 1996.
Author: Dominguez et al., Title: Effect of Heat Treatment on the Antigen-Binding Activity of Anti-Peroxidase Immunoglobins in Bovine Colostrum, Publ: Journal of Dairy Science, vol./Iss: 80 (12), pp. 3182-3187, Date: Dec. 1, 1998.
Author: Elliott et al., Title: Analysis of Colloidal Gold Probes by Isoelectric Focusing in Agarose Gels, Publ: Analytical Biochemistry, vol./Iss: 186 (1), pp. 53-59, Date: Apr. 1, 1990.
Author: EPO Search Report, Title: EPO Application 04821049.6 Search Report, Publ: EPO Search Report, pp. 1-10, Date: Oct. 19, 2009.
Author: EPO Searching Authority, Title: Search Report EPO-Application No. 02729092.3, Publ: EPO Search Report, pp. 1-6, Date: Jul. 13, 2009.
Author: EPO Searching Authority, Title: Search Report EPO—Application No. 02729092.3, Publ: EPO Search Report, pp. 1-6, Date: Jul. 13, 2009.
Author: Fraker et al., Title: Passive Immunization Against Tumor Necrosis Factor Partially Abrogates Interleukin 2 Toxicity, Publ: The Journal of Experimental Medicine, vol./Iss: 170, pp. 1015-1020, Date: Jan. 1, 1989.
Author: Gallego et al., Title: Ultrastructural Identification of the Splenic Follicular Dendritic Cells in the Chicken, Publ: The Anatomical Record, vol./Iss: 242, pp. 220-224, Date: Jan. 1, 1995.
Author: Goldstein et al., Title: Cardiovascular Effects of Platelet-Activating Factor, Publ: Lipids, vol./Iss: 26 (212), pp. 1250-1256, Date: Jan. 1, 1991.
Author: Grainger et al., Title: Polymeric Monolayers on Solid Substrates by Spontaneous Adsorption from Solution, Publ: American Chemical Society-Abstracts of Papers, vol./Iss: Part I, pp. Paragraph 074, Date: Aug. 20, 1995.
Author: Grainger et al., Title: Polymeric Monolayers on Solid Substrates by Spontaneous Adsorption from Solution, Publ: American Chemical Society—Abstracts of Papers, vol./Iss: Part I, pp. Paragraph 074, Date: Aug. 20, 1995.
Author: Gref et al., Title: The Controlled Intravenous Delivery of Drugs using PEG-Coated Sterically Stabilized Nanospheres, Publ: Advanced Drug Delivery Reviews, vol./Iss: 16, pp. 215-233, Date: Jan. 1, 1995.
Author: Hashimoto et al., Title: Action Site of Circulating Interleukin-1 on the Rabbit Brain, Publ: Brain Research, vol./Iss: 540, pp. 217-223, Date: Jan. 1, 1991.
Author: Hisamatsu et al., Title: Platelet Activating Factor Induced Respiratory Mucosal Damage, Publ: Lipids, vol./Iss: 26 (12), pp. 1287-1291, Date: Jan. 1, 1991.
Author: Hopkins et al., Title: Early Events Following the Bindnig of Epidermal Growth Factor to Surface Receptors on Ovarian Granulosa Cells, Publ: European Journal of Cell Biology, vol./Iss: 24, pp. 259-264, Date: Jan. 1, 1981.
Author: Ishii et al., Title: Preparation of Functionally PEGylated Gold Nanoparticles with Narrow Distribution through Autoreduction of Auric Cation by a-Biotinyl-PEG-block-[poly(2-N,N-dimethylamineo)ethyl methyacrylate)], Publ: Langmuir, vol./Iss: 20, pp. 561-564, Date: Feb. 3, 2004.
Author: Ito et al., Title: Antitumor Reactivity of Anti-CD3/Anti-CD28 Bead-Activated Lymphoid Cells: Implications for Cell Therapy in a Murine Model, Publ: Journal of Immunotherapy, vol./Iss: 26 (3), pp. 222-233, Date: Jan. 1, 2003.
Author: Japanese Patent Office, Title: Japanese Patent Application 2000-520153 Office Action as translated by Foreign Associate, Publ: Japanese Office Action, pp. 1-10, Date: Oct. 6, 2009.
Author: Japanese Publication, Title: Japanese Laid-Open Publication No. 9-107980 English Abstract only-of Japanese Patent Application 08-231415, pp. 1-3, Date: Apr. 28, 1997.
Author: Japanese Publication, Title: Japanese Laid-Open Publication No. 9-107980 English Abstract only—of Japanese Patent Application 08-231415, pp. 1-3, Date: Apr. 28, 1997.
Author: Kang et al., Title: Ultrastructural and Immunocytochemical Study of the Uptake and Distribution of Bacterial Lipopolysaccharide in Human Monocytes, Publ: Journal of Leukocyte Biology, pp. 316-332, Date: Jan. 1, 1990.
Author: Kimball, Title: Chapter 7-B Lymphocytes, Publ: Introduction to Immunology, pp. 184-190, Date: Jan. 1, 1990.
Author: Kimball, Title: Chapter 7—B Lymphocytes, Publ: Introduction to Immunology, pp. 184-190, Date: Jan. 1, 1990.
Author: Kirchner et al., Title: The Development of Neutralizing Antibodies in a Patient Receiving Subcutaneous Recombinant and Natural Interleukin-2, Publ: Cancer, vol./Iss: 67 (7), pp. 1862-1864, Date: Apr. 1, 1991.
Author: Koganty, R.R., Title: Vaccine Safety: A Case for Synthetic Vaccine Formulations, Publ: Expert Review of Vaccines, vol./Iss: 2(6), pp. 725-727, Date: Dec. 1, 2003.
Author: Koning, et al., Title: Selective Transfer of a Lipophilic Prodrug of 5-Fluorodeoxyuridine from Immunoliposomes to Colon Cancer Cells, Publ: Biochimica et Biphysica Acta, vol./Iss: 1420, pp. 153-167, Date: Jun. 2, 1999.
Author: Lang et al., Title: A New Class of Thiolipids for the Attachment of Lipid Bilayers on Gold Surfaces, Publ: Langmuir, vol./Iss: 10 (1), pp. 197-210, Date: Jan. 1, 1994.
Author: Lanzavecchia, Title: Identifying Strategies for Immune Interventor, Publ: Science, vol./Iss: 260, pp. 937-944, Date: Jan. 1, 1993.
Author: Lemmon et al., Title: Preperation and Characterization of Nanocomposites of Poly(ethylene oxide) with Layered Solids, Publ: New Techniques and Approaches, vol./Iss: Chapter 5, pp. 43-54, Date: Jan. 1, 1995.
Author: Leuvering et al., Title: A Sol Particle Agglutination Assay for Human Chorionic Gonadotrophin, Publ: Journal of Immunological Methods, vol./Iss: 45 (2), pp. 183-194, Date: Jan. 1, 1981.
Author: Lezzi et al., Title: Chelating Resins Supporting Dithiocarbamate and Methylthiourea Groups in Adsorption of Heavy Metal Ions, Publ: Journal of Applied Polymer Science, vol./Iss: 54 (7), pp. 889-897, Date: Nov. 14, 1994.
Author: Lezzi et al., Title: Synthesis of Thiol Chelating Resins and Their Adsorption Properties toward Heavy Metal Ions, Publ: Journal of Polymer Science, vol./Iss: 32, pp. 1877-1883, Date: Jan. 1, 1994.
Author: Li et al., Title: Plasma Protein Interactions with Copolymer-Stabilized Colloids, Publ: Dissertation Abstracts International, vol./Iss: 54 (7), pp. 3755-B, Date: Jan. 1, 1994.
Author: Li et al., Title: Self-Assembled Multilayers of Alternating Gold Nanoparticles and Dithols: Approaching to Superlattice, Publ: Colloids and Surfaces A, vol./Iss: 175, pp. 217-223, Date: Jan. 1, 2000.
Author: Magez et al., Title: Specific Uptake of Tumor Necrosis Factor-a is Involved in Growth Control of Trypanosoma brucei, Publ: The Journal of Cell Biology, vol./Iss: 137 (3), pp. 715-727, Date: May 5, 1997.
Author: Mantis, N.J., Title: Vaccines Against the Category B Toxins? Staphylococcal Enterotoxin B, Epsilon Toxin and Ricin, Publ: Advanced Drug Delivery Reviews, vol./Iss: 57, pp. 1424-1439, Date: Jun. 17, 2005.
Author: Mathias et al., Title: Sulfur-Substituted Polyoxyethylenes Sequential Ether-Thioether Copolymers, Publ: Crown Ethers and Phase Transfers Catalysis in Polymer Science, pp. 359-370, Date: Jan. 1, 1984.
Author: Morris et al., Title: Validation of the Biotinyl Ligand-Avidin-Gold Technique, Publ: Cytochemistry, vol./Iss: 40, pp. 711-721, Date: Jan. 1, 1992.
Author: Mrksich et al., Title: Surface Plasmon Resonance Permits in Situ Measurement of Protein Adsorption on Self-Assembled Monolayers of Alkanethiolates on Gold, Publ: Langmuir, vol./Iss: 11, pp. 4383-4385, Date: Jan. 1, 1995.
Author: Nakashima et al., Title: Electrochemical Characterization of an Assembled Monolayer of a-Methoxy-w-mercapto-poly(ethylene glycol) on Gold and Complex Formation of the Monolayer with a-Cyclodextrin, Publ: Chemistry Letters, pp. 731-732, Date: Jan. 1, 1996.
Author: Niwa et al., Title: Two-Dimensional Array of Poly(methacrylic acid) Brushes on Gold Substrates, Interaction with Ferrocen-Terminated Poly(oxyethylene)s, Publ: Macromolecules, vol./Iss: 28 (23), pp. 7770-7774, Date: Nov. 6, 1995.
Author: Ohmann et al., Title: Expression of Tumor Necrosis Factor-a Receptors on Bovine Macrophages, Lymphocytes and Polymorphonuclear Luekocytes, Internalization of Receptor-Bound Ligand, and Some Functional Effects, Publ: Lymphokine Research, vol./Iss: 9 (1), pp. 43-58, Date: Jan. 1, 1990.
Author: Otsuka et al., Title: Quantitative and Reversible Lectin-Induced Association of Gold Nanoparticles Modified with a-Lactosyl-w-mercapto-poly(ethylene glycol), Publ: Journal of the American Chemical Society, vol./Iss: 123, pp. 8226-8230, Date: Feb. 20, 2001.
Author: Paciotti et al. Title: (XP-001537149) #1048-The Use of Colloidal Gold in Cytokine Immununotherapy, Publ: Proceedings of the American Association for Cancer Research, vol./Iss: 39, pp. 153, Date: Mar. 1, 1998.
Author: Paciotti et al. Title: (XP-001537149) #1048—The Use of Colloidal Gold in Cytokine Immununotherapy, Publ: Proceedings of the American Association for Cancer Research, vol./Iss: 39, pp. 153, Date: Mar. 1, 1998.
Author: Paciotti et al., Title: (XP-001537146) #3858-Comparison of the Toxicity and Pharmacokinetics of Neat Gold Bound TNF, Publ: Proceedings of the American Association for Cancer Research, vol./Iss: 40, pp. 585, Date: Mar. 1, 1999.
Author: Paciotti et al., Title: (XP-001537146) #3858—Comparison of the Toxicity and Pharmacokinetics of Neat Gold Bound TNF, Publ: Proceedings of the American Association for Cancer Research, vol./Iss: 40, pp. 585, Date: Mar. 1, 1999.
Author: Paciotti et al., Title: Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery, Publ: Drug Delivery, vol./Iss: 11 (3), pp. 169-183, Date: May 1, 2004.
Author: Paciotti et al., Title: Interleukin 1 Directly Regulates Hormone-Dependent Human Breast Cancer Cell Proliferation in Vitro, Publ: Molecular Endocrinology, vol./Iss: 2, pp. 459-464, Date: Jan. 1, 1988.
Author: Paciotti et al., Title: Interleukin 1a Differentially Synchronizes Estrogen Dependent and Estrogen-Independent Human Breast Cells in G0/G1 Phase of the Cell Cycle, Publ: Anti-Cancer Research, vol./Iss: 11, pp. 25-32, Date: Jan. 1, 1991.
Author: Paciotti et al., Title: Interleukin 2 Differentially Effects the Proliferatino of a Hormone-Dependent and a Hormone-Independent Human Breast Cancer Cell Line in Vitro and in Vivo, Publ: Anti-Cancer Research, vol./Iss: 8, pp. 1233-1240, Date: Jan. 1, 1988.
Author: Peters et al. Title: Binding and Internalization of Biotinylated Interleukin-2 in Human Lymphocytes, Publ: Blood, vol./Iss: 76, pp. 97-104, Date: Jan. 1, 1990.
Author: Prakken et al. Title: Artificial Antigen-Presenting Cells as a Tool to Exploit the Immune ‘Synapse’, Publ: Nature Medicine, vol./Iss: 6 (12), pp. 1406-1410, Date: Dec. 1, 2000.
Author: Prakken et al. Title: Artificial Antigen-Presenting Cells as a Tool to Exploit the Immune 'Synapse', Publ: Nature Medicine, vol./Iss: 6 (12), pp. 1406-1410, Date: Dec. 1, 2000.
Author: Prime et al. Title: Adsorption of Proteins onto Surfaces Containing End-Attached Oligo(ethylene oxide): A Model System Using Self-Assembled Monolayers, Publ: Journal of the American Chemical Society, vol./Iss: 115, pp. 10714-10721, Date: Jan. 1, 1993.
Author: Rabolt, J.F. Title: Design and Construction of Two Component Heterogenous Polymer Surfaces by Self Assembly, Publ: Polymer Preprints, vol./lss: 36 (1), pp. 84, Date: Apr. 1, 1995.
Author: Roitt et al., Title: The Cytokine Network, Publ: Immunology, vol./Iss: 3rd ed., pp. 8-15, Date: Jan. 1, 1993.
Author: Stolnik et al., Title: The Effect of Surface Coverage and Conformation of Poly(ethylene oxide) (PEO) Chains of Poloxamer 407 on the Biological Fate of Model Colloidal Drug Carriers, Publ: Biochimica et Biphysica Acta, vol./Iss: 1514, pp. 261-279, Date: Oct. 1, 2001.
Author: Tomii et al. Title: Production of Anti-Platelet-Activating Factor Antibodies by the Use of Colloidal Gold as Carrier, Publ: Japanes Journal of Medical Science and Biology, vol./Iss: 44, pp. 75-80, Date: Jan. 1, 1991.
Author: Van Rensen et al., Title: Liposomes with Incorporated MHC Class II/Peptide Complexes as Antigen Presenting Vesicles for Specific T Cell Activation, Publ: Pharmaceutical Research, vol./Iss: 16 (2), pp. 198-204, Date: Jan. 1, 1999.
Author: Vidal et al., Title: Steric Stabilization of Polystyrene Colloids Using Thiol-ended Polyethylene Oxide, Publ: Polymers for Advanced Technologies, vol./Iss: 6, pp. 473-479, Date: Nov. 15, 1994.
Author: Walden et al., Title: Induction of Regulatory T-lymphocyte Responses by Liposomes Carrying Major Histocompatibility Complex Molecules and Foreign Antigen, Publ: Nature, vol./Iss: 315, pp. 327-329, Date: May 23, 1985.
Title: AU Office Action-Application No. 2004311630, Publ: Australian Office Action, pp. 1-4, Date: Oct. 9, 2009.
Title: AU Office Action—Application No. 2004311630, Publ: Australian Office Action, pp. 1-4, Date: Oct. 9, 2009.
Title: EPO Supplementary Search Report-04821049.6, Publ: EPO Search Report, pp. 1-11, Date: Oct. 19, 2009.
Title: EPO Supplementary Search Report—04821049.6, Publ: EPO Search Report, pp. 1-11, Date: Oct. 19, 2009.
Title: Office Action-Peoples Republic of China-Application No. 200480041234.5, Publ: Peoples Republic of China-Office Action, pp. 1-18, Date: Jun. 27, 2008.
Title: Office Action—Peoples Republic of China—Application No. 200480041234.5, Publ: Peoples Republic of China—Office Action, pp. 1-18, Date: Jun. 27, 2008.
Title: PCT International Search Report cited in PCT/US04/40785, Publ: PCT International Search Report, pp. 1-2, Date: Oct. 25, 2005.
Title: PCT International Search Report cited in PCT/US08/82984, Publ: PCT International Search Report, pp. 1-4, Date: Feb. 3, 2009.
Title: USPTO Office Action-cited in U.S. Appl. No. 11/046,204, Publ: USPTO Office Action, pp. 1-20 Date: Oct. 16, 2008.
Title: USPTO Office Action—cited in U.S. Appl. No. 11/046,204, Publ: USPTO Office Action, pp. 1-20 Date: Oct. 16, 2008.
Title: USPTO Office Action-cited in U.S. Appl. No. 11/516,175, Publ: USPTO Office Action, pp. 1-9, Date: Jun. 5, 2009.
Title: USPTO Office Action—cited in U.S. Appl. No. 11/516,175, Publ: USPTO Office Action, pp. 1-9, Date: Jun. 5, 2009.
Title: USPTO Office Action-cited in U.S. Appl. No. 12/549,207, Publ: USPTO Office Action, pp. 1-8, Date: Aug. 17, 2010.
Title: USPTO Office Action—cited in U.S. Appl. No. 12/549,207, Publ: USPTO Office Action, pp. 1-8, Date: Aug. 17, 2010.
Title: USPTO Office Action-U.S. Appl. No. 11/004,623, Publ: USPTO Office Action, pp. 1-12, Date: Aug. 5, 2008.
Title: USPTO Office Action—U.S. Appl. No. 11/004,623, Publ: USPTO Office Action, pp. 1-12, Date: Aug. 5, 2008.
Title: USPTO Office Action-U.S. Appl. No. 11/004,623, Publ: USPTO Office Action, pp. 1-22, Date: Feb. 22, 2007.
Title: USPTO Office Action—U.S. Appl. No. 11/004,623, Publ: USPTO Office Action, pp. 1-22, Date: Feb. 22, 2007.
Title: USPTO Office Action-U.S. Appl. No. 11/004623, Publ: USPTO Office Action, pp. 1-16, Date: Nov. 6, 2007.
Title: USPTO Office Action—U.S. Appl. No. 11/004623, Publ: USPTO Office Action, pp. 1-16, Date: Nov. 6, 2007.
US8486663B2 (en) * 2007-11-08 2013-07-16 Cytlmmune Sciences, Inc. Compositions and methods for generating antibodies
EP2219458B1 (en) 2015-07-15 grant
EP2219458A1 (en) 2010-08-25 application
US8486663B2 (en) 2013-07-16 grant
WO2009062151A1 (en) 2009-05-14 application
EP2219458A4 (en) 2011-11-30 application
US20110275123A1 (en) 2011-11-10 application
CA2706700A1 (en) 2009-05-14 application
US20090148908A1 (en) 2009-06-11 application
Zan et al. 1998 CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-β: evidence for TGF-β but not IL-10-dependent direct Sμ→ Sα and sequential Sμ→ Sγ, Sγ→ Sα DNA recombination
Brekke et al. 2003 Therapeutic antibodies for human diseases at the dawn of the twenty-first century
DeKruyff et al. 1997 Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40.
Cerutti et al. 1998 CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+ IgD+ B cell line
WO2009133208A1 (en) 2009-11-05 Improved fibronectin-based binding molecules and uses thereof
Kehry et al. 1994 Regulation of CD40 ligand expression and use of recombinant CD40 ligand for studying B cell growth and differentiation
WO2008144757A1 (en) 2008-11-27 Novel rabbit antibody humanization methods and humanized rabbit antibodies
WO2013087912A1 (en) 2013-06-20 Compounds and methods for treating inflammatory diseases
Snapper et al. 1995 Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. A redefinition of the TI-2 vs T cell-dependent antigen dichotomy.
Hermann et al. 1995 CD40 ligand‐positive CD8+ T cell clones allow B cell growth and differentiation
Luger et al. 2004 A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulation
Haurum 2006 Recombinant polyclonal antibodies: the next generation of antibody therapeutics?
Zhang et al. 2001 The distinct roles of T cell-derived cytokines and a novel follicular dendritic cell-signaling molecule 8D6 in germinal center-B cell differentiation
Snapper et al. 1993 Natural killer cells induce activated murine B cells to secrete Ig.
WO1996032418A1 (en) 1996-10-17 Anti-cd14 antibodies for use in the induction of il-10 secretion